Darren S. Cline's most recent trade in Pliant Therapeutics Inc was a trade of 26,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
Pyxis Oncology Inc
|
Cline Darren S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 35,219 | 251,405 | - | 0 | Common Stock | |
Impel Pharmaceuticals Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
Impel Pharmaceuticals Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 20,013 | 20,013 | - | - | Stock Option (right to buy) | |
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 139,355 | 216,186 | - | 0 | Common Stock | |
Pliant Therapeutics Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 66,831 | 76,831 | - | 0 | Common Stock | |
Pyxis Oncology Inc
|
Darren S. Cline | Director | Purchase of securities on an exchange or from another person at price $ 9.39 per share. | 08 Dec 2021 | 10,000 | 10,000 | - | 9.4 | 93,885 | Common Stock |
Pyxis Oncology Inc
|
Darren S. Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 42,191 | 42,191 | - | - | Stock Option (Right to buy) |